Please Wait
Applying Filters...
Xls
2D Structure
Also known as: Sydnocarb, Sidnocarb, 34262-84-5, Mesocarb [inn], Umt8mp2ndu, Mlr-1017
Molecular Formula
C18H18N4O2
Molecular Weight
322.4  g/mol
InChI Key
OWFUPROYPKGHMH-UHFFFAOYSA-N
FDA UNII
UMT8MP2NDU

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-phenyl-N'-[3-(1-phenylpropan-2-yl)oxadiazol-3-ium-5-yl]carbamimidate
2.1.2 InChI
InChI=1S/C18H18N4O2/c1-14(12-15-8-4-2-5-9-15)22-13-17(24-21-22)20-18(23)19-16-10-6-3-7-11-16/h2-11,13-14H,12H2,1H3,(H-,19,20,21,23)
2.1.3 InChI Key
OWFUPROYPKGHMH-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(CC1=CC=CC=C1)[N+]2=NOC(=C2)N=C(NC3=CC=CC=C3)[O-]
2.1.5 Isomeric SMILES
CC(CC1=CC=CC=C1)[N+]2=NOC(=C2)/N=C(/NC3=CC=CC=C3)\[O-]
2.2 Other Identifiers
2.2.1 UNII
UMT8MP2NDU
2.3 Synonyms
2.3.1 MeSH Synonyms

1. N-phenylcarbamoyl-3-(beta-phenylisopropyl)sydnonimine

2. Sidnocarb

3. Sydnocarb

2.3.2 Depositor-Supplied Synonyms

1. Sydnocarb

2. Sidnocarb

3. 34262-84-5

4. Mesocarb [inn]

5. Umt8mp2ndu

6. Mlr-1017

7. Mesocarbum

8. Mesocarbo

9. Sidnokarb

10. Sydnone Imine, 3-(1-methyl-2-phenylethyl)-n-((phenylamino)carbonyl)-

11. N-phenyl-n'-[3-(1-phenylpropan-2-yl)oxadiazol-3-ium-5-yl]carbamimidate

12. Unii-umt8mp2ndu

13. Mesocarbum [inn-latin]

14. Mesocarbo [inn-spanish]

15. Brn 5773701

16. Mesocarb [mart.]

17. Mesocarb [who-dd]

18. Mls000556315

19. Schembl727658

20. 3-(beta-phenylisopropyl)-n-phenyl Carbamoylsidnonimin

21. Chembl2105246

22. Chembl3989800

23. Dtxsid10900961

24. Hms2326a20

25. Sydnone Imine, 3-(.alpha.-methylphenethyl)-n-(phenylcarbamoyl)-

26. Stk548667

27. Akos005476412

28. Ncgc00246489-01

29. Smr000147632

30. 3-(alpha-methylphenethyl)-n-(phenylcarbamoyl)sydnone Imine

31. Sydnone Imine, 3-(alpha-methylphenethyl)-n-(phenylcarbamoyl)-

32. 3-(.alpha.-methylphenethyl)-n-(phenylcarbamoyl)sydnone Imine

33. (5z)-5-[(phenylcarbamoyl)imino]-3-(1-phenylpropan-2-yl)-4,5-dihydro-1,2,3-oxadiazol-3-ium-4-ide

34. 1,2,3-oxadiazolium, 3-(1-methyl-2-phenylethyl)-5-(((phenylamino)carbonyl)amino)-, Inner Salt

35. 178936-15-7

2.4 Create Date
2006-10-20
3 Chemical and Physical Properties
Molecular Weight 322.4 g/mol
Molecular Formula C18H18N4O2
XLogP34.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count6
Exact Mass322.14297583 g/mol
Monoisotopic Mass322.14297583 g/mol
Topological Polar Surface Area77.4 Ų
Heavy Atom Count24
Formal Charge0
Complexity406
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anticonvulsants

Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)


Antidepressive Agents

Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)


Central Nervous System Stimulants

A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)


Sympathomimetics

Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)